Bitcoin

In a market gripped by Extreme Fear (Fear & Greed at 9) and a broad macro risk-off tone, any positive non-crypto catalyst—especially in high-growth fields like oncology—can accelerate capital outflows from volatile assets like Bitcoin. Investors seeking refuge may interpret this as a sign that traditional R&D continues to offer compelling risk-adjusted returns, reducing the narrative pressure on crypto to serve as a hedge or growth asset.

Researchers published a study in Nature describing molecular glue degraders of the RNA-binding protein HuR that suppress BRAF-mutant colorectal cancer, indicating therapeutic potential.